🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Arrhythmias Detection in a Real World Population

Recruitingn/aAges any - anyAllFondazione IRCCS Policlinico San Matteo di Pavia
NCT02275637 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The study is a prospective multicenter registry. Consecutive patients with indications of implant / replacement or upgrade of implantable cardioverter defibrillator (ICD) will be enrolled. The primary objective of the study is to determine the predictors of appropriate anti-tachycardia therapy (with shock) in a non-selected population of patients implanted with an ICD. Secondary objectives of the study are: * the incidence of anti-tachycardia therapies; * the predictors of inappropriate therapy and onset of arrhythmia burden; * the adherence to the current guidelines in the Italian clinical practice; * the predictors of heart failure (HF) onset and response to cardiac resynchronization therapy (CRT).

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patient implanted with a Subcutaneous (S)- Ventricular Chamber (VR)- Dual Chamber (DR) - or Cardiac Resynchronization Therapy (CRT) Defibrillator (this study will utilize all the market released CRT-D or VR/DR-ICD systems and leads) * Patient is willing and able to sign an authorization to use and disclose health information or an Informed Consent * Patient must be able to attend all required follow-up visits at the study center for at least 12 months Exclusion Criteria: * Patient is participating in another clinical study that may have an impact on the study endpoints * Women who are pregnant or plan to become pregnant
💊

What it tests

  • implantable cardioverter defibrillator
📍

Where

12 sites
Ospedale Papa Giovanni XXIII
Bergamo, Italy
Policlinico S.Orsola-Malpighi
Bologna, Italy
P.O. Rodolico-San Marco
Catania, Italy
Azienda Ospedaliero Universitaria Careggi
Florence, Italy
ASST Rhodense- Ospedale di Rho
Milan, Italy
IRCCS S.Ambrogio-Galeazzi
Milan, Italy
Ospedale dei Colli Monaldi
Naples, Italy
University of Padua
Padua, Italy

…and 4 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy